Misplaced Pages

:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox: Difference between revisions - Misplaced Pages

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
< Misplaced Pages:WikiProject Chemicals | Chembox validation Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 16:31, 10 January 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 456598584 of page Zafirlukast for the Chem/Drugbox validation project (updated: 'DrugBank').← Previous edit Revision as of 16:31, 10 January 2012 edit undoBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 466286376 of page Zaleplon for the Chem/Drugbox validation project (updated: 'DrugBank').Next edit →
Line 1: Line 1:
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}} {{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}}
{{Drugbox {{Drugbox
| Verifiedfields = changed | Verifiedfields = changed
⚫ | verifiedrevid = 420280181
| Watchedfields = changed
| IUPAC_name = ''N''-(3-(3-cyanopyrazolo pyrimidin-7-yl)phenyl)-''N''- ethylacetamide
⚫ | verifiedrevid = 415866192
| image = Zaleplon Structural Formulae V.1.svg
| IUPAC_name = cyclopentyl 3-{2-methoxy-4-benzyl}-1-methyl-1''H''-indol-5-ylcarbamate
⚫ | width = 140
| image = Zafirlukast.svg
⚫ | width = 250
| image2 = Zafirlukast 3D ball-and-stick.png


<!--Clinical data--> <!--Clinical data-->
| tradename = Accolate | tradename = Sonata
| Drugs.com = {{drugs.com|monograph|zafirlukast}} | Drugs.com = {{drugs.com|monograph|zaleplon}}
| MedlinePlus = a697007 | MedlinePlus = a601251
| pregnancy_US = C
| pregnancy_category = B1 <small>(Australia)</small>, B <small>(United States)</small>
| legal_US = Schedule IV
| legal_status = ] <small>(UK)</small>
| routes_of_administration = Oral | routes_of_administration = Oral


<!--Pharmacokinetic data--> <!--Pharmacokinetic data-->
| bioavailability = Unknown | bioavailability = 30% (oral)
⚫ | metabolism = ]
| protein_bound = 99%
⚫ | elimination_half-life = 1 hour
⚫ | metabolism = ] (]-mediated)
⚫ | excretion = ]
⚫ | elimination_half-life = 10 hours
⚫ | excretion = Biliary


<!--Identifiers--> <!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}} | CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}} | CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 107753-78-6 | CAS_number = 151319-34-5
| ATC_prefix = R03 | ATC_prefix = N05
| ATC_suffix = DC01 | ATC_suffix = CF03
| PubChem = 5717 | PubChem = 5719
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00549 | DrugBank = DB00962
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 5515 | ChemSpiderID = 5517
| UNII_Ref = {{fdacite|correct|FDA}} | UNII_Ref = {{fdacite|correct|FDA}}
| UNII = XZ629S5L50 | UNII = S62U433RMH
| KEGG_Ref = {{keggcite|correct|kegg}} | KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00411 | KEGG = D00530
| ChEBI_Ref = {{ebicite|changed|EBI}} | ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 10100 | ChEBI = 10102
| ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 603 | ChEMBL = 1521


<!--Chemical data--> <!--Chemical data-->
| C=31 | H=33 | N=3 | O=6 | S=1 | C=17 | H=15 | N=5 | O=1
| molecular_weight = 575.676 ]/] | molecular_weight = 305.34
| smiles = O=S(=O)(c1ccccc1C)NC(=O)c2ccc(c(OC)c2)Cc4c3cc(ccc3n(c4)C)NC(=O)OC5CCCC5 | smiles = O=C(N(c3cccc(c1ccnc2c(C#N)cnn12)c3)CC)C
| InChI = 1/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35) | InChI = 1/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3
| InChIKey = YEEZWCHGZNKEEK-UHFFFAOYAR | InChIKey = HUNXMJYCHXQEGX-UHFFFAOYAO
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35) | StdInChI = 1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YEEZWCHGZNKEEK-UHFFFAOYSA-N | StdInChIKey = HUNXMJYCHXQEGX-UHFFFAOYSA-N
}} }}

Revision as of 16:31, 10 January 2012

This page contains a copy of the infobox ({{drugbox}}) taken from revid 466286376 of page Zaleplon with values updated to verified values.
WikiProject Chemicals/Chembox validation/VerifiedDataSandbox
Clinical data
Trade namesSonata
AHFS/Drugs.comMonograph
MedlinePlusa601251
Routes of
administration		Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability30% (oral)
MetabolismHepatic
Elimination half-life1 hour
ExcretionRenal
Identifiers
IUPAC name
  • N-(3-(3-cyanopyrazolo pyrimidin-7-yl)phenyl)-N- ethylacetamide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC17H15N5O
Molar mass305.34 g·mol
3D model (JSmol)
SMILES
  • O=C(N(c3cccc(c1ccnc2c(C#N)cnn12)c3)CC)C
InChI
  • InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3
  • Key:HUNXMJYCHXQEGX-UHFFFAOYSA-N
  (what is this?)  (verify)